These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 6936982)
1. [Reduced allergen immunotherapy of grass pollinosis (author's transl)]. Horak F; Jäger S; Skoda-Türk R Wien Klin Wochenschr Suppl; 1980; 117():36-8. PubMed ID: 6936982 [TBL] [Abstract][Full Text] [Related]
2. [Hyposensitization with cross-reacting pollen allergens]. Karl S; Rakoski J Z Hautkr; 1988; 63 Suppl 4():55-7. PubMed ID: 3252627 [TBL] [Abstract][Full Text] [Related]
3. [A modified therapy of hayfever with a depot-preparation (author's transl)]. Skoda-Türk R; Horak F; Jäger S Wien Klin Wochenschr Suppl; 1980; 117():24-6. PubMed ID: 6936978 [TBL] [Abstract][Full Text] [Related]
4. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937 [TBL] [Abstract][Full Text] [Related]
5. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684 [TBL] [Abstract][Full Text] [Related]
6. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study. Hordijk GJ; Antvelink JB; Luwema RA Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731 [TBL] [Abstract][Full Text] [Related]
7. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually. Panzner P; Petrás M; Sýkora T; Lesná I Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830 [TBL] [Abstract][Full Text] [Related]
9. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract]. Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. Frew AJ; Powell RJ; Corrigan CJ; Durham SR; J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133 [TBL] [Abstract][Full Text] [Related]
11. Hyposensitization in hay fever with grass pollen extracts: a three-year study comparing a dialysed alum adsorbed extract with allpyral. Haahtela T; Wihl JA; Munch E; Vilkka V; Hagelund CH; Watson HK Ann Allergy; 1984 May; 52(5):355-62. PubMed ID: 6721260 [TBL] [Abstract][Full Text] [Related]
12. [How and when is immunotherapy for pollen allergy carried out?]. Kersten W Med Klin; 1980 Oct; 75(21):751-4. PubMed ID: 7453622 [TBL] [Abstract][Full Text] [Related]
13. Which allergen extract for grass pollen immunotherapy? An in vitro study. Marcucci F; Sensi L; Di Cara G; Incorvaia C; Puccinelli P; Scurati S; Frati F Immunol Invest; 2010; 39(6):635-44. PubMed ID: 20653430 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy. Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368 [TBL] [Abstract][Full Text] [Related]
15. The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children. Rolinck-Werninghaus C; Hamelmann E; Keil T; Kulig M; Koetz K; Gerstner B; Kuehr J; Zielen S; Schauer U; Kamin W; Von Berg A; Hammermann J; Weinkauf B; Weidinger G; Stenglein S; Wahn U; Allergy; 2004 Sep; 59(9):973-9. PubMed ID: 15291906 [TBL] [Abstract][Full Text] [Related]
16. Rush immunotherapy with sublingual administration of grass allergen extract. Feliziani V; Marfisi RM; Parmiani S Allergol Immunopathol (Madr); 1993; 21(5):173-8. PubMed ID: 8160561 [TBL] [Abstract][Full Text] [Related]
17. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. Roberts G; Hurley C; Turcanu V; Lack G J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125 [TBL] [Abstract][Full Text] [Related]
18. Comparison between rush immunotherapy with a standardized allergen and an alum adjuved pyridine extracted material in grass pollen allergy. Bousquet J; Guerin B; Dotte A; Dhivert H; Djoukhadar F; Hewitt B; Michel FB Clin Allergy; 1985 Mar; 15(2):179-93. PubMed ID: 3888440 [TBL] [Abstract][Full Text] [Related]
19. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens. Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414 [TBL] [Abstract][Full Text] [Related]
20. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR J Allergy Clin Immunol; 2001 Jun; 107(6):971-6. PubMed ID: 11398073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]